Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy
Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy
Glucotrack完成植入式連續血糖監測器的60天臨床前研究；確認了對於疼痛性糖尿病神經病變的簡化管理潛力。
Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy
Glucotrack完成了植入式持續血糖監測儀60天的臨床研究，確認其在疼痛性糖尿病性神經病變簡化管理方面的潛力。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。